BioRestorative Therapies, Inc. - 8-K Filing

BioRestorative Therapies appoints new interim CEO and CFO following transition of Katharyn Field (Items: 4.01 Changes in Registrant’s Certifying Accountant, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $BRTX

Read the full article at SEC EDGAR

More Regulatory news